tiprankstipranks
Trending News
More News >
AbbVie (DE:4AB)
XETRA:4AB
Germany Market

AbbVie (4AB) Technical Analysis

Compare
20 Followers

Summary of all the Indicators

Overall Consensus
Sell
6Bullish
2Neutral
14Bearish
Technical Analysis Consensus
Buy
5Bullish
2Neutral
3Bearish
Moving Average Consensus
Strong Sell
1Bullish
0Neutral
11Bearish
AbbVie’s (4AB) Moving Averages Convergence Divergence (MACD) indicator is -9.82, suggesting AbbVie is a Buy.
AbbVie’s (4AB) 20-Day exponential moving average is 170.09, while AbbVie’s (4AB) share price is €153, making it a Sell.
AbbVie’s (4AB) 50-Day exponential moving average is 177.58, while AbbVie’s (4AB) share price is €153, making it a Sell.

AbbVie (4AB) Pivot Points

Apr 18, 2025, 12:21 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
155.20
155.80
156.60
157.20
158.00
158.60
159.40
Fibonacci
155.80
156.33
156.67
157.20
157.73
158.07
158.60
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

AbbVie (4AB) Moving Averages

Apr 18, 2025, 12:21 AM
Period
Simple
Exponential
MA5
152.96Buy
155.57Sell
MA10
160.62Sell
161.17Sell
MA20
174.97Sell
170.09Sell
MA50
184.43Sell
177.58Sell
MA100
176.01Sell
176.47Sell
MA200
172.08Sell
170.88Sell
AbbVie’s (4AB) 10-Day exponential moving average is 161.17, while AbbVie’s (4AB) share price is €153, making it a Sell.
AbbVie’s (4AB) 100-Day exponential moving average is 176.47, while AbbVie’s (4AB) share price is €153, making it a Sell.
AbbVie’s (4AB) stock price is €153 and AbbVie’s (4AB) 50-day simple moving average is 184.43, creating a Sell signal.
AbbVie’s (4AB) stock price is €153 and AbbVie’s (4AB) 100-day simple moving average is 176.01, creating a Sell signal.
AbbVie’s (4AB) stock price is €153 and AbbVie’s (4AB) 200-day simple moving average is 172.08, creating a Sell signal.

AbbVie (4AB) Technical Indicators

Apr 18, 2025, 12:21 AM
Name
Value
Implied Action
RSI (14)
29.26
Buy
STOCH (9,6)
16.97
Buy
STOCHRSI (14)
14.59
Buy
MACD (12,26)
-9.82
Buy
ADX (14)
36.98
Neutral
Williams %R
-90.97
Buy
CCI (14)
-98.60
Neutral
ATR (14)
6.72
-
Ultimate Oscillator
20.88
Sell
ROC
-17.58
Sell
AbbVie’s (4AB) Relative Strength Index (RSI) is 29.26, creating a Buy signal.
AbbVie’s (4AB) Trend Strength Indicator (ADX) is 36.98, creating a Neutral signal.
AbbVie’s (4AB) Commodity Channel Index (CCI) is -98.60, creating a Neutral signal.
AbbVie’s (4AB) Price Rate of Change (ROC) is -17.58, creating a Sell signal.

FAQ

Is 4AB a Buy, Hold, or Sell?
Based on 4AB’s technical indicators, 4AB is a Sell.
    What is 4AB’s RSI (14)?
    4AB’s RSI (14) is 29.26, which suggests 4AB is a Buy.
      What is 4AB’s MACD?
      4AB’s MACD is -9.82, which suggests 4AB is a Buy.
        What is 4AB’s 5-day moving average?
        4AB’s 5-day moving average is 152.96, which suggests 4AB is a Buy.
          What is 4AB’s 20-day moving average?
          4AB 20-day moving average is 174.97, which suggests 4AB is a Sell.
            What is 4AB’s 50-day moving average?
            4AB’s 50-day moving average is 184.43, which suggests 4AB is a Sell.
              What is 4AB’s 200-day moving average?
              4AB’s 200-day moving average is 172.08, which suggests 4AB is a Sell.
                What is 4AB’s Williams % R (14)?
                4AB’s Williams % R (14) is -90.97, which suggests 4AB is a Buy.
                  What is 4AB’s CCI (14)?
                  4AB’s CCI (14) is -98.60, which suggests 4AB is a Neutral.
                    What is the share price of AbbVie?
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis